Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Administration Newborn (0-1 years) Children (2-9 years) Tuberculosis Diphtheria Tetanus Pertussis Measles
Economic aspects All age groups Influenza Rotavirus Meningococcal disease Pneumococcal disease Hepatitis B Varicella
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Recommendation Costa Rica Rotavirus
Download:
Agenda & Minutes Netherlands Rotavirus
Download:
Agenda & Minutes Netherlands Rotavirus
Download:
Agenda & Minutes Netherlands Rotavirus
Download:
Indonesia Tetanus
Download: